Jianming Guo Selected Research

Leukopenia

1/2021	Dose escalation and expansion (phase Ia/Ib) study of GLS-010, a recombinant fully human antiprogrammed death-1 monoclonal antibody for advanced solid tumors or lymphoma.
6/2019	A multicenter observational study of the real-world use of docetaxel for metastatic castration-resistant prostate cancer in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jianming Guo Research Topics

Disease

73	Neoplasms (Cancer) 04/2024 - 04/2015
47	Renal Cell Carcinoma (Grawitz Tumor) 12/2024 - 01/2015
15	Urinary Bladder Neoplasms (Bladder Cancer) 12/2023 - 01/2016
12	Prostatic Neoplasms (Prostate Cancer) 10/2023 - 01/2016
8	Inflammation (Inflammations) 01/2024 - 09/2015
8	Ischemia 08/2021 - 03/2014
7	Dysmenorrhea (Menstrual Pain) 06/2016 - 04/2010
6	Thrombosis (Thrombus) 05/2024 - 01/2014
6	Neoplasm Metastasis (Metastasis) 11/2023 - 09/2016
5	Chronic Renal Insufficiency 11/2020 - 09/2015
5	Fibrosis (Cirrhosis) 10/2020 - 08/2012
4	Carcinoma (Carcinomatosis) 11/2023 - 01/2021
4	Pain (Aches) 09/2021 - 02/2011
4	Chronic Kidney Failure (Chronic Renal Failure) 04/2019 - 11/2016
3	Carotid Stenosis (Carotid Artery Stenosis) 05/2024 - 08/2016
3	Hypertension (High Blood Pressure) 02/2024 - 01/2022
3	Hemorrhage 01/2023 - 08/2016
3	Non-Muscle Invasive Bladder Neoplasms 01/2023 - 01/2022
3	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2012
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020 - 07/2016
3	Hematoma 12/2016 - 09/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2024 - 02/2018
2	Rupture 01/2024 - 08/2016
2	Peripheral Arterial Disease 01/2023 - 04/2015
2	Infections 01/2023 - 01/2022
2	Diabetic Cardiomyopathies 09/2022 - 10/2020
2	Hyperplasia 08/2021 - 12/2016
2	Leukopenia 01/2021 - 06/2019
2	Hypoxia (Hypoxemia) 10/2020 - 01/2016
2	Arteriovenous Fistula 01/2020 - 12/2017
2	Wounds and Injuries (Trauma) 01/2020 - 12/2018
2	Disease Progression 06/2019 - 02/2017
2	Type 2 Diabetes Mellitus (MODY) 04/2019 - 04/2014
2	Ulcer 11/2018 - 01/2018
2	Dysbiosis 03/2018 - 02/2018
2	False Aneurysm (Pseudoaneurysm) 01/2018 - 12/2016
2	Fistula 12/2017 - 12/2016

Drug/Important Bio-Agent (IBA)

21	Tyrosine Kinase InhibitorsIBA 12/2024 - 11/2016
18	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2013
10	Proteins (Proteins, Gene)FDA Link 06/2023 - 01/2016
8	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 12/2024 - 01/2023
8	LigandsIBA 01/2024 - 01/2016
7	CytokinesIBA 01/2020 - 01/2013
6	Immune Checkpoint InhibitorsIBA 05/2024 - 11/2020
6	Therapeutic UsesIBA 01/2023 - 01/2019
6	Sunitinib (Sutent)FDA Link 01/2022 - 11/2016
5	Sorafenib (BAY 43-9006)FDA Link 04/2021 - 11/2016
3	Axitinib (AG 013736)IBA 05/2024 - 10/2021
3	Phenobarbital (Luminal)FDA Link 01/2024 - 01/2020
3	Circular RNAIBA 07/2021 - 01/2018
3	CalciumIBA 03/2021 - 04/2010
3	Docetaxel (Taxotere)FDA Link 01/2021 - 06/2019
3	Messenger RNA (mRNA)IBA 01/2021 - 01/2016
3	danhongIBA 01/2020 - 07/2016
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2018 - 07/2016
3	Ethanol (Ethyl Alcohol)IBA 11/2016 - 04/2010
3	Shao-Fu-Zhu-YuIBA 06/2016 - 02/2011
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2016 - 09/2015
2	Phosphotransferases (Kinase)IBA 04/2024 - 01/2022
2	VaccinesIBA 12/2023 - 01/2023
2	RNA (Ribonucleic Acid)IBA 10/2023 - 01/2022
2	Programmed Cell Death 1 ReceptorIBA 06/2023 - 01/2018
2	NitrogenIBA 01/2023 - 05/2020
2	Everolimus FDA Link 01/2023 - 10/2020
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 05/2020
2	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 01/2022
2	Gemcitabine FDA Link 01/2023 - 01/2022
2	LipidsIBA 05/2022 - 10/2020
2	PlatinumIBA 03/2022 - 01/2021
2	CreatinineIBA 01/2022 - 05/2020
2	Uremic ToxinsIBA 11/2020 - 04/2019
2	NivolumabIBA 10/2020 - 01/2020
2	CC ChemokinesIBA 01/2020 - 04/2017
2	Adenine FDA LinkGeneric 02/2018 - 11/2016
2	Histones (Histone)IBA 08/2017 - 12/2016
2	AnaphylatoxinsIBA 12/2016 - 01/2016
2	catalpolIBA 01/2016 - 12/2015
2	loganinIBA 01/2016 - 09/2015
2	acteosideIBA 01/2016 - 12/2015
2	morronisideIBA 01/2016 - 09/2015
2	Immunoglobulin G (IgG)IBA 01/2016 - 12/2014
2	myrrh resin (myrrh)IBA 10/2015 - 09/2015
2	FrankincenseIBA 10/2015 - 09/2015

Therapy/Procedure

36	Therapeutics 12/2024 - 09/2010
18	Nephrectomy 04/2024 - 04/2015
17	Immunotherapy 12/2024 - 01/2020
8	Drug Therapy (Chemotherapy) 01/2023 - 12/2019
7	Chinese Traditional Medicine (Traditional Chinese Medicine) 05/2019 - 05/2013
6	Operative Time 01/2023 - 04/2015
5	Stents 05/2024 - 08/2017
4	Length of Stay 01/2023 - 08/2015
4	Surgical Amputation (Amputations) 01/2023 - 01/2018
4	Oral Administration 12/2015 - 10/2011
3	Castration 10/2023 - 06/2019
2	Lasers (Laser) 05/2024 - 01/2022
2	Cystectomy 01/2023 - 01/2020
2	Neoadjuvant Therapy 01/2023 - 01/2018
2	Punctures 01/2022 - 12/2016
2	Adjuvant Chemotherapy 01/2020 - 01/2020
2	Lithotripsy (Extracorporeal Shockwave Lithotripsy) 02/2018 - 04/2016